Bluejay DiagnosticsBJDX
13F holders, Q1 2026 (March 31)6holders +5
6new positions
1sold out
$1.84avg. 13F price*
At the end of Q1 2026, 6 institutions reported holding Bluejay Diagnostics Inc. (BJDX) in their 13F filings, up 5 from Q4 2025. 6 opened new positions and 1 sold out. The largest holders were Sabby Management, LLC ($53K), Geode Capital Management, LLC ($52K) and Tower Research Capital LLC (TRC) ($3K).
- Company
- Bluejay Diagnostics Inc.
- CUSIP
- 095633608
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $108K |
| Exits | 1 | $1 |
All 13F filers, Q4 2025 → Q1 2026: 58,829 shares bought and 1 shares sold, net +58,828 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Sabby Management, LLC | 1.00% | New | 28,726 | $53K |
| Geode Capital Management, LLC | 0.00% | New | 28,127 | $52K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,729 | $3K |
| UBS Group AG | 0.00% | New | 124 | $228 |
| L1 Global Manager Pty Ltd | 0.00% | New | 120 | $220 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 3 | $6 |
"% of holder's portfolio" is BJDX's weight in each manager's 13F, not the share of Bluejay Diagnostics Inc. the manager owns.